Status:
UNKNOWN
Evaluation of the Efficacy in Decreasing Iron Absorption in Patients With Congenital Dyserythropoietic Anemia Type I by Treatment With LOSEC
Lead Sponsor:
Soroka University Medical Center
Conditions:
CDA Type I
Eligibility:
All Genders
12+ years
Phase:
PHASE4
Brief Summary
Congenital Dyserythropoietic Anemia Type I (CDAI) is a recessive autosomal disease caused by ineffective erythropoiesis that causes Anemia \& accumulation of iron due to increased absorption of iron i...
Detailed Description
The aim of this study is to check whether treatment with drug which inhibits the hydrogen pump and therefore decreases acidity, will reduce the iron's absorption in patients with CDA TYPE I and whethe...
Eligibility Criteria
Inclusion
- patients with CDAI
- over 30 kg
- can swallow tablets
- ferritin levels higher than the normal range but still don't require treatment.
Exclusion
- N.A
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2013
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT01795794
Start Date
April 1 2013
End Date
December 1 2013
Last Update
February 27 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.